Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Eur J Med Chem
; 90: 170-83, 2015 Jan 27.
Article
in En
| MEDLINE
| ID: mdl-25461318
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Pyridines
/
Drug Design
/
Niacinamide
/
Proto-Oncogene Proteins B-raf
/
Protein Kinase Inhibitors
/
Imidazoles
/
Neoplasms, Experimental
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Eur J Med Chem
Year:
2015
Document type:
Article
Affiliation country:
China
Country of publication:
France